cdn mobile

FDA warns vs fake paracetamol tablets

By: Inquirer.net March 26,2018 - 10:23 AM

According to the FDA, the difference between the genuine and the counterfeit paracetamol brand can be seen in the tablet’s color and packaging features. —Photos from FDA

The Food and Drug Administration (FDA) has warned consumers against the purchase and consumption of counterfeit Biogesic paracetamol 500-milligram tablets.

In an advisory, the FDA said United Laboratories Inc., the marketing authorization holder for the drug, had verified the presence of the fake product in the local market.

“All health care professionals and the general public are hereby warned as to the availability of this counterfeit drug product in the market, which poses potential danger or injury to consumers,” the agency said.

The authentic product and the counterfeit item differ in tablet color, foil packaging pattern, foil material, and printed markings.

The importation and sale of counterfeit medicines are prohibited under Republic Act No. 9711 or the Food and Drug Administration Act of 2009, as well as Republic Act No. 8203, or the Special Law on Counterfeit Drugs.

“All establishments and outlets are hereby warned against selling and dispensing of this verified counterfeit drug product with the above mentioned features,’’ the agency said.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: FDA, tablets, warns
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.